-
1
-
-
0014893444
-
Combination chemotherapy in the treatment of advanced Hodgkin's disease
-
DeVita VT Jr, Serpick AA, Carbone PP. Combination chemotherapy in the treatment of advanced Hodgkin's disease. Ann Intern Med 1970; 73: 881-895.
-
(1970)
Ann. Intern. Med
, vol.73
, pp. 881-895
-
-
DeVita V.T., Jr.1
Serpick, A.A.2
Carbone, P.P.3
-
2
-
-
0016707139
-
Combination chemotherapy of Hodgkin's disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide versus MOPP
-
Bonadona G, Zucali R, Monfardini S et al. Combination chemotherapy of Hodgkin's disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide versus MOPP. Cancer 1975; 36: 252-259.
-
(1975)
Cancer
, vol.36
, pp. 252-259
-
-
Bonadona, G.1
Zucali, R.2
Monfardini, S.3
-
3
-
-
0022553175
-
Twenty years of MOPP therapy for Hodgkin's disease
-
Longo DL, Young RC, Wesley M et al. Twenty years of MOPP therapy for Hodgkin's disease. J Clin Oncol 1986; 4: 1295-1306.
-
(1986)
J. Clin. Oncol
, vol.4
, pp. 1295-1306
-
-
Longo, D.L.1
Young, R.C.2
Wesley, M.3
-
4
-
-
0011440695
-
Chemotherapy for Hodgkin's disease. Section II: Alternative combinations and new approaches
-
Selby P, McElwain TJ (eds): Oxford: Blackwell Scientific Publications
-
Canellos GP, Selby P, McElwain TJ. Chemotherapy for Hodgkin's disease. Section II: alternative combinations and new approaches. In Selby P, McElwain TJ (eds): Hodgkin's Disease. Oxford: Blackwell Scientific Publications 1987; 285-300.
-
(1987)
Hodgkin's Disease
, pp. 285-300
-
-
Canellos, G.P.1
Selby, P.2
McElwain, T.J.3
-
5
-
-
0026439199
-
Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVD
-
Canellos GP, Anderson JR, Propert KJ et al. Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVD. N Engl J Med 1992; 327: 1478-1484.
-
(1992)
N. Engl. J. Med
, vol.327
, pp. 1478-1484
-
-
Canellos, G.P.1
Anderson, J.R.2
Propert, K.J.3
-
6
-
-
0031033626
-
Outcome of patients with Hodgkin's disease failing after primary MOPP-ABVD
-
Bonfante V, Santoro A, Viviani S et al. Outcome of patients with Hodgkin's disease failing after primary MOPP-ABVD. J Clin Oncol 1997; 15: 528-534.
-
(1997)
J. Clin. Oncol
, vol.15
, pp. 528-534
-
-
Bonfante, V.1
Santoro, A.2
Viviani, S.3
-
7
-
-
0011449354
-
Conventional-dose salvage combination chemotherapy in patients relapsing with Hodgkin's disease after combination chemotherapy: The low probability for cure
-
Longo DL, Duffey PL, Young RC et al. Conventional-dose salvage combination chemotherapy in patients relapsing with Hodgkin's disease after combination chemotherapy: the low probability for cure. J Clin Oncol 1997; 15: 528-534.
-
(1997)
J. Clin. Oncol
, vol.15
, pp. 528-534
-
-
Longo, D.L.1
Duffey, P.L.2
Young, R.C.3
-
8
-
-
0026329564
-
Autologous bone marrow transplantation for patients with relapsed Hodgkin's disease
-
Armitage JO, Bierman PJ, Vose JM et al. Autologous bone marrow transplantation for patients with relapsed Hodgkin's disease. Am J Med 1991; 91: 605-611.
-
(1991)
Am. J. Med
, vol.91
, pp. 605-611
-
-
Armitage, J.O.1
Bierman, P.J.2
Vose, J.M.3
-
9
-
-
0027742164
-
High dose sequential chemoradiotherapy with peripheral blood progenitor cell support for relapsed or refractory Hodgkin's disease. A 6-year update
-
Gianni AM, Siena S, Bregni M et al. High dose sequential chemoradiotherapy with peripheral blood progenitor cell support for relapsed or refractory Hodgkin's disease. A 6-year update. Ann Oncol 1993; 4: 889-891.
-
(1993)
Ann. Oncol
, vol.4
, pp. 889-891
-
-
Gianni, A.M.1
Siena, S.2
Bregni, M.3
-
10
-
-
0027404777
-
Dose intensification with autologous bone-marrow transplantation in relapsed and resistant Hodgkin's disease: Results of a BNLI randomised trial
-
Linch DC, Winfield D, Goldstone AH et al. Dose intensification with autologous bone-marrow transplantation in relapsed and resistant Hodgkin's disease: results of a BNLI randomised trial. Lancet 1993; 341: 1051-1054.
-
(1993)
Lancet
, vol.341
, pp. 1051-1054
-
-
Linch, D.C.1
Winfield, D.2
Goldstone, A.H.3
-
11
-
-
0014258292
-
International conference on leukaemia-lymphoma
-
Benzel JE. International conference on leukaemia-lymphoma, Ann Arbor, Michigan. Del Med J 1967; 40: 78-81.
-
(1967)
Ann Arbor. Michigan Del. Med. J
, vol.40
, pp. 78-81
-
-
Benzel, J.E.1
-
12
-
-
0021130371
-
Combination chemotherapy for advanced Hodgkin's disease after failure of MOPP, ABVD and B-CAVe
-
Harker WG, Kushlan P, Rosenberg SA. Combination chemotherapy for advanced Hodgkin's disease after failure of MOPP, ABVD and B-CAVe. Ann Intern Med 1984; 101: 440-446.
-
(1984)
Ann. Intern. Med
, vol.101
, pp. 440-446
-
-
Harker, W.G.1
Kushlan, P.2
Rosenberg, S.A.3
-
13
-
-
0029113713
-
Etoposide, vinblastine, and doxorubicin: An active regimen for the treatment of Hodgkin's disease in relapse following MOPP. Cancer and Leukemia Group B
-
Canellos GP, Petroni GR, Barcos M et al. Etoposide, vinblastine, and doxorubicin: an active regimen for the treatment of Hodgkin's disease in relapse following MOPP. Cancer and Leukemia Group B. J Clin Oncol 1995; 13: 2005-2011.
-
(1995)
J. Clin. Oncol
, vol.13
, pp. 2005-2011
-
-
Canellos, G.P.1
Petroni, G.R.2
Barcos, M.3
-
15
-
-
0023835089
-
Risk of second cancers after treatment for Hodgkin's disease
-
Tucker MA, Coleman CN, Cox RS et al. Risk of second cancers after treatment for Hodgkin's disease. N Engl J Med 1988; 318: 76-81.
-
(1988)
N. Engl. J. Med
, vol.318
, pp. 76-81
-
-
Tucker, M.A.1
Coleman, C.N.2
Cox, R.S.3
-
16
-
-
0024352213
-
Increased risk of lung cancer, non-Hodgkin's lymphoma, and leukemia following Hodgkin's disease
-
van Leeuwen FE, Somers R, Taal BG et al. Increased risk of lung cancer, non-Hodgkin's lymphoma, and leukemia following Hodgkin's disease. J Clin Oncol 1989; 7: 1046-1058.
-
(1989)
J. Clin. Oncol
, vol.7
, pp. 1046-1058
-
-
van Leeuwen, F.E.1
Somers, R.2
Taal, B.G.3
-
17
-
-
0000352307
-
Leukemias, non-Hodgkin's lymphomas and solid tumors in patients treated for Hodgkin's disease
-
Coleman C, Kaplan HS, Cox R et al. Leukemias, non-Hodgkin's lymphomas and solid tumors in patients treated for Hodgkin's disease. Cancer Surv 1982; 1: 733-743.
-
(1982)
Cancer Surv
, vol.1
, pp. 733-743
-
-
Coleman, C.1
Kaplan, H.S.2
Cox, R.3
-
18
-
-
0021062139
-
Second cancers after radiotherapy and chemotherapy for early stages of Hodgkin's disease
-
Henry-Amar M. Second cancers after radiotherapy and chemotherapy for early stages of Hodgkin's disease. J Natl Cancer Inst 1983; 71: 911-916.
-
(1983)
J. Natl. Cancer Inst
, vol.71
, pp. 911-916
-
-
Henry-Amar, M.1
-
19
-
-
0021964253
-
Lung cancer in Hodgkin's disease: Association with previous radiotherapy
-
List AF, Doll DC, Greco FA. Lung cancer in Hodgkin's disease: association with previous radiotherapy. J Clin Oncol 1985; 3: 215-221.
-
(1985)
J. Clin. Oncol
, vol.3
, pp. 215-221
-
-
List, A.F.1
Doll, D.C.2
Greco, F.A.3
-
20
-
-
0033816125
-
MiCMA: An alternative treatment for refractory or recurrent Hodgkin's disease
-
La Barbera EO, Chiusolo P, Laurenti L et al. MiCMA: an alternative treatment for refractory or recurrent Hodgkin's disease. Ann Oncol 2000; 11: 867-871.
-
(2000)
Ann. Oncol
, vol.11
, pp. 867-871
-
-
La Barbera, E.O.1
Chiusolo, P.2
Laurenti, L.3
-
21
-
-
0033846566
-
CN3OP: An active regimen in patients with relapsed/refractory Hodgkin's lymphoma
-
Walewski J, Krzyzanowska JB, Kraszewska E et al. CN3OP: an active regimen in patients with relapsed/refractory Hodgkin's lymphoma. Med Oncol 2000; 17: 195-202.
-
(2000)
Med. Oncol
, vol.17
, pp. 195-202
-
-
Walewski, J.1
Krzyzanowska, J.B.2
Kraszewska, E.3
-
22
-
-
0032947935
-
ChlVPP/ABV-VP16 hybrid regimen for advanced Hodgkin's disease: A study in 36 patients
-
Saletti P, Zucca E, Gueneau M et al. ChlVPP/ABV-VP16 hybrid regimen for advanced Hodgkin's disease: a study in 36 patients. Leuk Lymphoma 1999; 33: 313-319.
-
(1999)
Leuk. Lymphoma
, vol.33
, pp. 313-319
-
-
Saletti, P.1
Zucca, E.2
Gueneau, M.3
-
24
-
-
0023267126
-
MIME chemotherapy as treatment for recurrent Hodgkin's disease
-
Hagemeister FB, Tannir N, McLaughlin P et al. MIME chemotherapy as treatment for recurrent Hodgkin's disease. J Clin Oncol 1987; 5: 556-561.
-
(1987)
J. Clin. Oncol
, vol.5
, pp. 556-561
-
-
Hagemeister, F.B.1
Tannir, N.2
McLaughlin, P.3
-
25
-
-
0025337574
-
Methyl-GAG, ifosfamide, methotrexate and etoposide (MIME) as salvage therapy for Hodgkin's disease and non-Hodgkin's lymphoma. The Swedish Lymphoma Study Group
-
Enblad G, Glimelius B, Hagberg H, Lindemalm C. Methyl-GAG, ifosfamide, methotrexate and etoposide (MIME) as salvage therapy for Hodgkin's disease and non-Hodgkin's lymphoma. The Swedish Lymphoma Study Group. Acta Oncol 1990; 29: 297-301.
-
(1990)
Acta Oncol
, vol.29
, pp. 297-301
-
-
Enblad, G.1
Glimelius, B.2
Hagberg, H.3
Lindemalm, C.4
-
26
-
-
0031918129
-
Methyl-GAG, ifosfamide, methotrexate and etoposide (MIME) as salvage therapy for Hodgkin's disease: A prospective study
-
Enblad G, Hagberg H, Gustavsson A, Glimelius B. Methyl-GAG, ifosfamide, methotrexate and etoposide (MIME) as salvage therapy for Hodgkin's disease: a prospective study. Eur J Haematol 1998; 60: 166-171.
-
(1998)
Eur. J. Haematol
, vol.60
, pp. 166-171
-
-
Enblad, G.1
Hagberg, H.2
Gustavsson, A.3
Glimelius, B.4
-
27
-
-
0032976642
-
ESHAP is an active regimen for relapsing Hodgkin's disease
-
Aparicio J, Segura A, Garcera. S et al. ESHAP is an active regimen for relapsing Hodgkin's disease. Ann Oncol 1999; 10: 593-595.
-
(1999)
Ann. Oncol
, vol.10
, pp. 593-595
-
-
Aparicio, J.1
Segura, A.2
Garcera, S.3
-
28
-
-
0023484082
-
Lomustine, etoposide, vindesine, and dexamethasone (CEVD) in Hodgkin's lymphoma refractory to COPP and ABVD: A multicenter trial of German Hodgkin Study Group
-
Pfreundschuh MG, Schoppe WD, Fuchs R et al. Lomustine, etoposide, vindesine, and dexamethasone (CEVD) in Hodgkin's lymphoma refractory to COPP and ABVD: a multicenter trial of German Hodgkin Study Group. Cancer Treat Rep 1987; 71: 1203-1207.
-
(1987)
Cancer Treat. Rep
, vol.71
, pp. 1203-1207
-
-
Pfreundschuh, M.G.1
Schoppe, W.D.2
Fuchs, R.3
-
29
-
-
0029099436
-
The MINE regimen as intensive salvage chemotherapy for relapsed and refractory Hodgkin's disease
-
Ferme C, Bastion Y, Lepage E et al. The MINE regimen as intensive salvage chemotherapy for relapsed and refractory Hodgkin's disease. Ann Oncol 1995; 6: 543-549.
-
(1995)
Ann. Oncol
, vol.6
, pp. 543-549
-
-
Ferme, C.1
Bastion, Y.2
Lepage, E.3
-
31
-
-
0027722082
-
CAPE/PALE salvage chemotherapy for Hodgkin's disease patients relapsing within 1 year of ChlVPP chemotherapy
-
Fairey AF, Mead GM, Jones HE et al. CAPE/PALE salvage chemotherapy for Hodgkin's disease patients relapsing within 1 year of ChlVPP chemotherapy. Ann Oncol 1993; 4: 857-860.
-
(1993)
Ann. Oncol
, vol.4
, pp. 857-860
-
-
Fairey, A.F.1
Mead, G.M.2
Jones, H.E.3
-
32
-
-
0028245954
-
Results of CAV regimen (CCNU, melphalan, and VP-16) as third-line salvage therapy for Hodgkin's disease
-
Brusamolino E, Orlandi E, Canevari A et al. Results of CAV regimen (CCNU, melphalan, and VP-16) as third-line salvage therapy for Hodgkin's disease. Ann Oncol 1994; 5: 427-432.
-
(1994)
Ann. Oncol
, vol.5
, pp. 427-432
-
-
Brusamolino, E.1
Orlandi, E.2
Canevari, A.3
-
33
-
-
0033153007
-
ASHAP: A regimen for cytoreduction of refractory or recurrent Hodgkin's disease
-
Rodriguez J, Rodriguez MA, Fayad L et al. ASHAP: a regimen for cytoreduction of refractory or recurrent Hodgkin's disease. Blood 1999; 93: 3632-3636.
-
(1999)
Blood
, vol.93
, pp. 3632-3636
-
-
Rodriguez, J.1
Rodriguez, M.A.2
Fayad, L.3
-
34
-
-
0031892206
-
Vinblastine for recurrent Hodgkin's disease following autologous bone marrow transplant
-
Little R, Wittes RE, Longo DL, Wilson WH. Vinblastine for recurrent Hodgkin's disease following autologous bone marrow transplant. J Clin Oncol 1998; 16: 584-588.
-
(1998)
J. Clin. Oncol
, vol.16
, pp. 584-588
-
-
Little, R.1
Wittes, R.E.2
Longo, D.L.3
Wilson, W.H.4
-
35
-
-
0011449357
-
Phase II study of gemcitabine in patients with multiple pretreated Hodgkin's disease-results of multicenter study
-
Tesch H, Santoro A, Fiedler F et al. Phase II study of gemcitabine in patients with multiple pretreated Hodgkin's disease-results of multicenter study. Leuk Lymphoma 1998; 29 (Suppl 1): 103.
-
(1998)
Leuk. Lymphoma
, vol.29
, Issue.SUPPL. 1
, pp. 103
-
-
Tesch, H.1
Santoro, A.2
Fiedler, F.3
-
36
-
-
0033932803
-
Gemcitabine in treatment of refractory Hodgkin's disease: Results of a multicenter phase II study
-
Santoro A, Bredenfeld H, Devizzi L et al. Gemcitabine in treatment of refractory Hodgkin's disease: results of a multicenter phase II study. J Clin Oncol 2000; 18: 2615-2619.
-
(2000)
J. Clin. Oncol
, vol.18
, pp. 2615-2619
-
-
Santoro, A.1
Bredenfeld, H.2
Devizzi, L.3
-
37
-
-
0032761285
-
Ifosfamide, carboplatin, and etoposide: A highly effective cytoreduction and peripheral-blood progenitor cell mobilization regimen for transplant-eligible patients with non-Hodgkin's lymphoma
-
Moskowitz CH, Bertino JR, Glassman JR et al. Ifosfamide, carboplatin, and etoposide: a highly effective cytoreduction and peripheral-blood progenitor cell mobilization regimen for transplant-eligible patients with non-Hodgkin's lymphoma. J Clin Oncol 1999; 17: 3776-3785
-
(1999)
J. Clin. Oncol
, vol.17
, pp. 3776-3785
-
-
Moskowitz, C.H.1
Bertino, J.R.2
Glassman, J.R.3
-
38
-
-
0028819356
-
Mini-BEAM as salvage therapy for relapsed or refractory Hodgkin's disease before intensive therapy and autologous bone marrow transplantation
-
Colwill R, Crump M, Couture F et al. Mini-BEAM as salvage therapy for relapsed or refractory Hodgkin's disease before intensive therapy and autologous bone marrow transplantation. J Clin Oncol 1995; 13: 396-402.
-
(1995)
J. Clin. Oncol
, vol.13
, pp. 396-402
-
-
Colwill, R.1
Crump, M.2
Couture, F.3
-
39
-
-
0032448066
-
The case for and against high-dose chemotherapy with stem cell rescue for early poor prognosis Hodgkin's disease in first remission
-
Goldstone A. The case for and against high-dose chemotherapy with stem cell rescue for early poor prognosis Hodgkin's disease in first remission. Ann Oncol 1998; 9 (Suppl): 83-85.
-
(1998)
Ann. Oncol
, vol.9
, Issue.SUPPL.
, pp. 83-85
-
-
Goldstone, A.1
-
40
-
-
0033783428
-
High-dose therapy with peripheral blood stem cell transplantation for patients with relapsed or refractory Hodgkin's disease: Long-term outcome and prognostic factors
-
Neben K, Hohaus S, Goldschmidt H et al. High-dose therapy with peripheral blood stem cell transplantation for patients with relapsed or refractory Hodgkin's disease: long-term outcome and prognostic factors. Ann Hematol 2000; 79: 547-555.
-
(2000)
Ann. Hematol
, vol.79
, pp. 547-555
-
-
Neben, K.1
Hohaus, S.2
Goldschmidt, H.3
|